AbbVie And Gilgamesh Pharmaceuticals | Announce Collaboration And Option-to-License Agreement To Develop Next-Generation Therapies For Psychiatric Disorders - Global Search, Local Care | The Future of Medical Consultation


ChatMedical.AI, an innovator in AI healthcare, is a key subsidiary of UL Cell Therapeutic, a leading medical research firm based in Singapore with significant operations in North America and Asia